Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRG.L Regulatory News (PRG)

  • There is currently no data for PRG

Subscription

15 Nov 2013 14:55

PARAGON DIAMONDS LTD - Subscription

PARAGON DIAMONDS LTD - Subscription

PR Newswire

London, November 15

15 November 2013 Paragon Diamonds Limited ("Paragon" or the "Company") (AIM: PRG) Subscription to raise £3 million Paragon Diamonds Limited is pleased to announce that it has raised £3 million(before expenses) by way of a subscription (the "Subscription") with anexisting shareholder for a total of 60,000,000 new ordinary shares at 5p each(the "Subscription Shares"). The Subscription was arranged by Sanlam SecuritiesUK Limited. Use of Proceeds The net proceeds raised will be used to provide additional capital to developthe Company's Lemphane Kimberlite project in Lesotho, for which the Company wasrecently awarded a Mining Lease, and for working capital purposes generally. Subscription The Company will issue the Subscription Shares under its existing shareauthorities. Lanstead Capital L.P. ("Lanstead"), an institutional investor and existingshareholder of the Company, has subscribed for the Subscription Shares for anaggregate consideration of £3 million. In addition, the Company has enteredinto an Equity Swap Agreement with Lanstead which allows the Company to retainmuch of the economic interest in the Subscription Shares. The Equity Swap Agreement provides that the Company's economic interest will bedetermined and payable in twenty-four settlement tranches as measured against abenchmark price of 6.67p per share ("the Benchmark Price"). If the measuredshare price exceeds the Benchmark Price, for that month, the Company willreceive more than 100 per cent of the monthly settlement due on a pro ratabasis. There is no upper limit placed on the additional proceeds receivable bythe Company as part of the monthly settlements. Should the measured share pricebe below the Benchmark Price, the Company will receive less than 100 per centof the expected monthly settlement on a pro rata basis. In no case would adecline in the Company's share price result in any increase in the number ofordinary shares received by Lanstead or any other advantage accruing toLanstead. The Company has agreed to make a value payment to Lanstead of £400,000 inconsideration for the Equity Swap Agreement within 60 days of Admission of theSubscription Shares which the Company may elect to settle by the issue toLanstead of a further 6,000,000 new ordinary shares. The Equity Swap Agreementallows the Company to secure much of the potential upside arising fromnear-term news flow. The mid-market price of the Company's existing ordinary shares at the close ofbusiness on 14 November 2013 (being the latest practicable day prior to thepublication of this announcement) was 4.17p. The Subscription is conditional onadmission of the Subscription Shares to AIM which is expected to becomeeffective on 19 November 2013. The Subscription Shares will, when issued and fully paid, rank pari passu inall respects with the Company's existing ordinary shares, including the rightto receive any dividend or other distribution thereafter declared, made orpaid. Following Admission, the Company's issued share capital will comprise288,595,917 ordinary shares. Executive Chairman, Martin Doyle commented: "We are pleased with the continued support from Lanstead which allows us tofurther advance our flagship Lemphane Kimberlite project in Lesotho." For further information: Paragon Diamonds Limited +44 (0) 20 7099 1940 Martin Doyle - Chairman Simon Retter - Finance Director www.paragondiamonds.com Sanlam Securities UK (Nominated Adviser & +44 (0) 20 7628 2200Broker) Lindsay Mair Catherine Miles
Date   Source Headline
9th May 201111:26 amRNSDirector/PDMR Shareholding
6th May 20117:00 amRNSOperational update
4th May 20117:00 amRNSDirector/PDMR Shareholding
21st Apr 20117:00 amRNSConditional Acquisition of IDC
21st Apr 20117:00 amRNSConditional Acquisition of IDC by Paragon Diamonds
25th Mar 20119:45 amRNSOperational Update
25th Mar 20117:45 amRNSOperational Update
25th Mar 20117:00 amRNSFinal Results
24th Mar 20117:00 amRNSChange of Registered Office
18th Mar 20117:00 amRNSAppointment of joint broker
1st Feb 20113:52 pmRNSHolding(s) in Company
31st Jan 20117:00 amRNSMabuki Project Update
27th Jan 20117:00 amRNSIssue of Equity
10th Jan 20117:00 amRNSDirector/PDMR Shareholding
6th Jan 20117:00 amRNSLicence Award
29th Dec 20109:43 amRNSNotification of Interest
22nd Dec 20107:00 amRNSAcquisition of ARR
15th Dec 20103:42 pmRNSNotification of interest
9th Dec 20107:00 amRNSAcquisition of interest in IDC
30th Nov 20107:00 amRNSOperational Update
22nd Nov 201011:02 amRNSDirector Dealings
19th Nov 20101:16 pmRNSAppointment of Director
10th Nov 20107:00 amRNSHeads of Agreement Signed
1st Nov 20107:00 amRNSAdmission to AIM
5th Jun 200810:59 amRNSCourt Approval of the Reducti
3rd Jun 200811:55 amRNSCourt Approval of Scheme
3rd Jun 20087:00 amRNSSuspension - Premier Research
29th May 20088:26 amRNSHolding(s) in Company
29th May 20088:20 amRNSHolding(s) in Company
28th May 200810:47 amRNSRule 8.3- PREMIER RESEARCH GR
22nd May 200811:18 amRNSRule 8.3-Premier Research Gro
21st May 20083:18 pmRNSHolding(s) in Company
20th May 20082:13 pmRNSRule 8.3- Premier Research Gr
20th May 200811:27 amRNSRule 8.3- Premier Research Gr
20th May 20088:09 amRNSEPT Disclosure
19th May 20084:55 pmRNSHolding(s) in Company
19th May 20084:48 pmRNSHolding(s) in Company
19th May 20084:47 pmRNSHolding(s) in Company
19th May 200812:36 pmRNSRule 8.3- Premier Research Gr
16th May 20089:29 amRNSEPT Disclosure
15th May 200812:25 pmRNSRule 8.3- Premier Research
14th May 200812:28 pmRNSRule 8.3- Premier Research
13th May 20087:46 amRNSEPT Disclosure
8th May 20081:03 pmBUSRule 8.3 - Premier Research Group PLC
8th May 200812:10 pmRNSRule 8.3- Premier Research Gr
8th May 20088:43 amRNSEPT Disclosure
7th May 200812:18 pmRNSResult of EGM
7th May 200810:20 amRNSEPT Disclosure
6th May 20083:20 pmRNSHolding(s) in Company
6th May 20088:33 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.